On the same date, Julian Gill also requested case numbers for all adverse events in the FAERS system related to tirzepatide and semaglutide products produced by Empower Pharmacy in Houston, Texas (both the 503A and 503B products). Noa Metta submitted on September 24 a request for FDA Form 483 inspection reports, warning letters, Establishment Inspection Reports, and adverse event reports relating to pharmacies conducting unauthorized compounding practices, involving semaglutide, tirzepatide, or similar drugs, between January 1, 2022, and the present. Several additional requests addressed non-compounding issues related to GLP-1 drugs, two mentioning Eli Lilly and one mentioning Ozempic and Wegovy
Step 4: Folate filtered by the kidneys Excess folate in the blood is filtered by the kidneys and reabsorbed
This equipment is well-positioned to save EMS personnel from debilitating back injuries and lengthy rehabilitations, the number one cause of career ending disability in the EMS industry
Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus
